In patients with COVID-19/diabetes comorbidity, antidiabetic drugs and insulin therapy have to be adapted accordingly.[77] In summary, the hub genes that we selected are closely related to a variety of key physiological and pathological processes, such as inflammation, oxidative stress, apoptosis, and immunity. Here, INS is linked to COVID-19.